Management of HIV/AIDS – Current Practice & Future Hopes

Authors

  • Dr. Marcia Waran
  • Brig. Dr. Arun Tyagi
  • Brig. Dr. A. K. Shrivastava

Keywords:

HIV, AIDS, ART, RNA Virus, CD4

Abstract

HIV/ AIDS pandemic, that started in the late twentieth century has continued into the 21st century despite all the research and effort to control it. It is estimated that more than 34.3 million people worldwide are infected with HIV and 18.6 million deaths have occurred. By 2020 about 20 million will be orphaned due to the virus. India has the highest number of people with HIV globally, second only to South Africa. There are approximately 16,000 new infections every day. The advent of ART revolutionized the lives of people living with HIV/ AIDS but ART is not  a cure; ART merely keeps the viral replication suppressed. When ART is stopped the virus rebounds within a few weeks in almost all infected individuals. Recently UNAIDS has recommended the new strategy for control of HIV infection (Test & Treat) and laid down new targets (90-90-90 by 2020). This article reviews the current practices in management of HIV/ AIDS and highlights the future diagnostic therapeutic and preventive modalities that may soon become available to the clinicians.

Downloads

Download data is not yet available.

References

Mark Heywood. Lancet Vol 3869989 July 2015.

Dr. Thomas A. Rasmussen Prof. Sharon R Lewin. Spotlight No. 15- July 2016 pgs. 103-104mark Heywood.Lencet vol 38699989,July 2015171-218

Branson BM, Handsfeild H, Lampe MO et al, Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Recomm. Rep.2006 Sept 22,55:1-17

Marcus Low & Kristanna Peris: Spotlight Science#15-July 2016 pgs 108-111

Kumaraswamy APN, Sanjay Pujari, Antiretroviral therapy in the Indian setting: When and what start, when and what to switch to? Indian journal of Medical Research. 2011: 1(134)787-800

NACO. Antiretroviral therapy guidelines for HIV infected Adults and Adolescents in India. NACO 2015. (updated Sept. 2013-12 June 2016

Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, WHO AIDS technical Bulletin. 20015,78.

Rerks-Ngarm S, Pilisuttithum P, Nitayaphan S, Kaewungwal J, Chiu J, Paris P, et al. Vaccination with ALVAS and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine. 2009; 361(23):2209-2C

Karuna ST, Mulligan MJ, Grove D et al Efficacy of a DNA/r Ad5 HIV-1 preventable vaccine. New England journal of Medicine. 2013; 369(22): 2083-92.

Cromwell Ta, Hatano H. Clinical outcomes and antiretroviral therapy in "elite" controllers: a review of literature. J. Virus Erad. 2015;1(2): 72-77

Downloads

Published

2017-06-13

How to Cite

Waran, D. M. ., Tyagi, B. D. A. ., & Shrivastava, B. D. A. K. . (2017). Management of HIV/AIDS – Current Practice & Future Hopes. VIMS Health Science Journal, 4(2), 89–93. Retrieved from https://vimshsj.edu.in/index.php/main/article/view/268

Issue

Section

Review Articles

Most read articles by the same author(s)